It has been claimed by the Ariad Pharmaceuticals Inc. that its experimental drug ponatinib is effective in improving the life of the patients suffering with chronic myeloid leukemia. The Ariad Pharmaceuticals is hopeful that its drug would pave the way for better and effective medication for leukemia.